|Articles|February 1, 2013
- Pharmaceutical Executive-02-01-2013
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - February 2013
2013 Oncology Practice Roundtable
Advertisement
Articles in this issue
over 13 years ago
Country Report: Australiaover 13 years ago
Turkey: A Promise Restored?over 13 years ago
NHTSA Addresses "Drugged Driving"over 13 years ago
Fortuity and the First Amendmentover 13 years ago
PE, February 2013 Cover Imageover 13 years ago
Oncology: Pathways to ProgressAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
2
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
3
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
4
The Evolving Relationship Between FDA and Biotech
5